ESMO Society Updates

The European Society for Medical Oncology (ESMO) announced today that the recipient of the 2025 Heine H. Hansen Award is Keith Kerr, Consultant Pathologist for NHS Grampian and Honorary Chair in Pulmonary Pathology at the University of Aberdeen in Scotland

Burnout is an increasingly pressing concern for the oncology community

This year marks the 10th anniversary of the ESMO Women for Oncology (W4O) Committee, a decade-long commitment to advancing gender equity in oncology

ESMO reaffirms its commitment to working with EU stakeholders to maximize the potential of the Beating Cancer Plan

Bringing together cancer patient advocates from around the world will create a bridge between diverse experiences and perspectives and help secure the optimisation of patient care worldwide

The nomination process for the 2025 ESMO Society Awards is now open

The European Society for Medical Oncology (ESMO) has announced today that the recipient of the 2025 TAT Honorary Award is Philippe Bedard

ESMO welcomes the outcome of the hearings for Olivér Várhelyi, Commissioner-designate for Health and Animal Welfare, where several topics relevant for the oncology community were addressed in a positive or at least promising way

The ESMO Award for Immuno-Oncology 2024 is presented to Ton N. Schumacher in recognition of his exceptional contributions to cancer immunology and to our understanding of the mechanism of how immunotherapy works

Bringing another annual reunion of the global oncology community to a resounding close, the 34,000 attendees of the ESMO Congress 2024 had the opportunity to gather around to listen to the most important results presented in different tumour types and research areas

ESMO is pleased to announce the 2024 ESMO Fellowship awardees

The ESMO Precision Medicine Working Group (PMWG) together with a multidisciplinary team of international experts, have developed the ESMO Tumour-Agnostic Classifier and Screener (ETAC-S)

The recipients of the 2024 ESMO Society Awards have been announced today by ESMO

Hundreds of trials are being delayed in Europe due to unintended consequences of the IVDR posing an existential threat to Europe’s role as a leader in global oncological research

The Impact Factor (IF) of ESMO journals has remained strong this year, according to the 2024 Journal Citation Reports published by Clarivate Analytics

ESMO has announced today the results of its Presidential elections following the closure of the voting system on Monday, 10 June 2024.

Tom Powles, Editor in Chief of ESMO’s flagship journal Annals of Oncology; Solange Peters, ESMO Past President; and Fabrice André, President Elect of the Society have been recognised as leading and influential researchers for their remarkable achievements in cancer care

Following the Ombudsman’s recent findings of maladministration regarding the Commission’s interactions with tobacco lobbyists and its subsequent decision not to bring forward the proposed Council recommendation on smoke-free environments, it is beyond belief that the Commission now appears to have removed plans to publish an evaluation – originally meant to come in 2022 - of the Tobacco Products Directive from its implementation

The European Society for Medical Oncology (ESMO) announced today that the 2024 ESMO Breast Cancer Award is conferred to Hope S. Rugo, Professor of Medicine and Winterhof Family Professor of Breast Cancer at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

The European Society for Medical Oncology (ESMO) announced today that the 2024 Heine H. Hansen Award is bestowed to Enriqueta Felip

The nomination process for the 2024 ESMO Society Awards is now open

ESMO is pleased to announce the newly appointed Committee and Working Group Chairs who started their mandates in January 2024

The European Society for Medical Oncology (ESMO) has announced today that the 2024 ESMO TAT Honorary Award is bestowed to Funda Meric-Bernstam

ESMO is pleased to announce the renewal of its status as non-State actor in official relations with the World Health Organization - a privilege granted to non-governmental organisations, which recognises ESMO’s sustained and systematic engagement in the interest of the WHO

An evidence-based and patient-centred approach to close the care gap for a healthier Europe

As the world observes Universal Health Coverage Day, ESMO anticipates the results of the latest study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines, highlighting a worrying stall over the last five years

The ESMO Award for Immuno-Oncology 2023 was bestowed to Steven A. Rosenberg in recognition of his exceptional contribution to the field of cancer immunology research.

After five days filled with practice-changing data, intense discussions and educational sessions addressing the needs and issues currently arising for oncology professionals and impacting patients with cancer worldwide, the ESMO Congress 2023 today sent home its more than 33,000 participants from 144 countries with plenty of food for thought and ample material to enrich their medical practice.

ESMO and ASCO, the two largest professional organisations for oncologists, have released the 2023 edition of their joint recommendations for the Curriculum for Training in Medical Oncology

ESMO expresses deep sorrow about all the ongoing tragic events that continue to happen in many parts of the world and joins the voices pressing for a rapid return to peace

We regret to inform you of an embargo breach in which late-breaking abstract data has been made available online ahead of the official publication schedule

The very first expert-based guidance for reporting real-world evidence studies specifically for oncology, “ESMO Guidance for Reporting Oncology real-World evidence (GROW)", has been developed by ESMO, together with the valuable contribution of external stakeholders.

Committed to delivering high-quality medical science and to helping the oncology community to stay up to date with the latest developments in the field, ESMO has expanded its portfolio of journals.

ESMO has announced today the winners of the 2023 ESMO Society Awards.

According to the 2023 Journal Citation Reports, the Impact Factor (IF) of ESMO Journals remains strong this year

The introduction of a specially validated version of the ESMO-MCBS (European Society for Medical Oncology-Magnitude of Clinical Benefit Scale) for heamatological malignancies, developed in collaboration with the European Hematology Association (EHA), represents a milestone in the development of value assessment in oncology

ESMO launched the ESMO Living Guidelines, a new tool designed to make the ESMO Clinical Practice Guidelines (CPGs) easier to use in oncologists’ routine clinical practice and support optimal decision-making in a rapidly evolving medical field

The European Society for Medical Oncology (ESMO) has announced today that the 2023 ESMO Breast Cancer Award is bestowed to Sara A. Hurvitz for her remarkable contributions to breast cancer clinical and laboratory-based research

The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced today that the 2023 Heine H. Hansen Award is conferred on Paul Baas for his outstanding contribution to thoracic oncology research

ESMO has announced today that the 2023 ESMO TAT Honorary Award is presented to Susan Bates

ESMO is pleased to announce that the nomination process for the 2023 ESMO Society Awards is now open.

ESMO renews its support to World Cancer Day (WCD) joining the #CloseTheCareGap campaign led by the Union for International Cancer Control (UICC). 

Andrés Cervantes started his two-year mandate as ESMO President on 1 January 2023. 

With more than 2.2 million new cases and nearly 1.8 million deaths in 2020, lung cancer represents 11.4% of the 19,292,789 new cases of cancer worldwide and 18% of its mortality.

The European Society for Medical Oncology (ESMO) has announced today that the winner of the ESMO Award for Immuno-Oncology 2022 is conferred on Nina Bhardwaj for her outstanding contribution to cancer immunology research.

ESMO has announced today the winners of the 2022 ESMO Society Awards.

Developed by the ESMO Precision Medicine Working Group, they provide guidance to medical oncologists on the use of circulating tumour DNA assays in clinical practice

ESMO has announced today the results of its Executive Board elections following the closure of the voting system on Monday 27 June 2022.

ESMO has announced today that the 2022 ESMO Breast Cancer Award is presented to Sibylle Loibl for her exceptional contribution to clinical research in breast cancer.  

In light of the challenging situation in Prague due to the ongoing arrival of refugees from Ukraine

The role of polygenic scores for stratified cancer prevention, and the genetic determinants for PSA levels to improve cancer screening utility will be debated during the sixth instalment in the World Cancer Report Updates webinar series.

The 2022 ESMO Heine H. Hansen Award is conferred on Fred R. Hirsch for his lifelong outstanding contribution to lung cancer research

Who will be the next ESMO Awardees? Submit your nominations before 9 March.

This year, World Cancer Day is launching #CloseTheCareGap, a three-year campaign aiming to promote awareness, collaboration, and action for a more equitable future in cancer care.

ESMO has announced today that the 2022 ESMO TAT Honorary Award is presented to Lesley K Seymour 

Based on current knowledge available, they address key questions on safety and efficacy of COVID-19 vaccines, their interference with anticancer treatment, and advocate for a global strategy for the booster dose 

ESMO President will act as an Advisor

ESMO delivered an official statement at the Special Session of the World Health Assembly to strengthen pandemic prevention, preparedness and response

The ESMO Immuno-Oncology Congress will be an online-only meeting

The collaborative study shows significant gaps in low- and middle-income countries

ESMO has announced today that the 2021 ESMO Award for Immuno-oncology is presented to Hervé Fridman

Experts discuss a wealth of challenges and opportunities in primary cancer prevention that oncologists themselves must take on  

With modest progress being made in the gender balance of the oncology field in recent years, women continue to be underrepresented in leadership positions despite making up an increasing proportion of the oncology workforce.

Over 200 leading health journals, including Annals of Oncology, published a joint editorial urging governments to take actions to limit global temperature increases, restore biodiversity, and protect health.

ESMO has announced today the winners of the 2021 Society Awards.

Record Impact Factor increases for ESMO journals 

An ESMO Women for Oncology survey warns the health crisis is widening the gender gap as data shows that female oncologists have managed to dedicate less time to science during and after lockdowns

Timely presentations of trial data will accelerate transition from research to practice

Decide is the Health Decision Hub hosted by the World Health Organisation

ESMO continues its commitment to improve cancer prevention worldwide through the collaboration with IARC 

ESMO has announced a collaboration with the WHO’s International Agency for Research on Cancer (IARC) to support them in the development of an online learning platform which integrates all research for cancer prevention in one easy-to-access point.

ESMO President Solange Peters and ESMO officers Paolo G. Casali and Elisabeth De Vries have been invited to speak at the virtual meeting [29 October] marking 25 years of EMA's strong commitment to protect public health with a focus on cancer

ESMO’s commitment in the region continues with a new plan for Pan-Asian adaptations of the ESMO Clinical Practice Guidelines

ESMO joined an EMA virtual meeting marking 25 years of its strong commitment to protect public health with a focus on cancer. Lectures from ESMO’s spokespersons were streamed. 

An ambitious European Programme of Work (EPW 2020–2025) – “United Action for Better Health in Europe” has just been adopted by WHO Europe at its virtual Regional Committee Meeting (14-15 September 2020)

ESMO has taken the decision due to the uncertain evolution of the Coronavirus pandemic in the Asia-Pacific region and to avoid any risks to the health of the Faculty, delegates and staff.

The European Society for Medical Oncology has announced the winners of the ESMO awards 2020.

ESMO will convene its Ordinary Annual General Assembly on 28 July 2020 in Lausanne, Switzerland, without physical presence of members, under the rules of the Swiss COVID-19 Ordinance 3.

On 29 June 2020, the Web of Science Group, a Clarivate Analytics company, released the 2020 Journal Citation Reports (JCR).

In the framework of a thorough review of our activities in light of the non-completely resolved Coronavirus pandemic, the ESMO Academy 2020 will be held as a virtual meeting.

A study published in Annals of Oncology (1) presents the first blood test that can accurately detect more than 50 types of cancer and identify in which tissue the cancer originated, often before there are any clinical signs or symptoms of the disease.

On ESMO Open, an analysis conducted by the Clinical Academic Cancer Research Forum (CAREFOR) together with selected industry representatives provides an overview on current models, challenges and effective strategies to improve collaborative efforts in oncology trials.

“Responsibility” is a keyword these days, both individual and collective responsibility

TAT 2020 Honorary Award recipient Lillian L. Siu discusses early evidence on how altering bacteria in the human gut of cancer patients may represent a new pioneering option of treatment.

The Editor-In-Chief of Annals of Oncology will be responsible for the development of research at the French institute.

The World Health Organization- WHO Report on Cancer released on 2020 World Cancer Day gives global recognition to ESMO tools supporting accessible cancer care.

Finding what you need is now easier than ever. 
Discover the new main features and enjoy the new websites at your office and when you are on the move. 

Two years ago, the World Health Organisation (WHO) invited the Society to assist in the evaluation of Kazakhstan’s cancer treatment protocols and medicines, which has led today to the improvement of cancer care services in the Asian country.